Understanding Physician Responsibilities and Limitations for Drug and Device Off-Label Use

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 2, 2007, Pages 251-254

  Sclafani, Anthony P ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE OIL;

DOCTOR PATIENT RELATION; DRUG APPROVAL; FACE SURGERY; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; INTERPERSONAL COMMUNICATION; LAW ENFORCEMENT; MALPRACTICE; MEDICAL ETHICS; MEDICAL PRACTICE; OFF LABEL DEVICE USE; OFF LABEL DRUG USE; PLASTIC SURGERY; REVIEW; RISK BENEFIT ANALYSIS; UNITED STATES;

DEVICE APPROVAL; DRUG APPROVAL; HUMANS; SOCIAL RESPONSIBILITY; SURGERY, PLASTIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34249662752     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2007.01.010     Document Type: Review

References (0)